Huiqiang Huang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-9090-1907

发表论文 95 篇 · 总被引 1151 次 · h-index 12

代表论文

• Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma (2025 · Cancer Discovery · 被引 11)
• Improved efficacy of concurrent anti-PD1 antibody plus AVD versus ABVD in patients with newly diagnosed early unfavorable and advanced stage classic Hodgkin lymphoma: a retrospective matched cohort study (2025 · Cancer Immunology Immunotherapy · 被引 3)
• Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications (2026 · Nature Communications)
• Supplementary Figure S4 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study (2026)
• Supplementary Table 4 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study (2026)
• Supplementary Figure S3 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study (2026)